Brian P. McKeon
Brian P. McKeon's purchase track record
Brian P. McKeon has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/12/2026 | XRAY | $101K | +3.7% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Baird Highlights Growth Potential for Alkermes plc (ALKS). Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
Transaction History
| XRAY | ▲ Buy | Open Market | 10,000 | $101K | 6/12/2026 | View on chart |
| XRAY | ▲ Buy | Grant | 28,887 | $0 | 6/3/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 6,142 | — | 5/21/2026 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,475 | $55K | 5/21/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 8,013 | — | 5/31/2025 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,924 | $59K | 5/31/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 252 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 303 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 308 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 299 | $0 | 2/14/2025 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 569 | $253K | 2/14/2025 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 117 | $53K | 8/5/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 192 | $0 | 8/5/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 6,104 | — | 6/29/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,465 | $35K | 6/29/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 483 | $100K | 2/15/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 435 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 432 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 253 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 303 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 308 | $0 | 2/14/2024 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 1,097 | $615K | 2/14/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 4,533 | — | 2/10/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,088 | $30K | 2/10/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 23,326 | $3.3M | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 615 | $347K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,581 | $893K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 701 | $397K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,564 | $887K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,469 | $836K | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,912 | $2.2M | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 5,675 | $3.2M | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 7,128 | $4.1M | 2/7/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 681 | $390K | 2/7/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 192 | $0 | 8/5/2023 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 117 | $59K | 8/5/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,430 | $43K | 7/7/2023 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,957 | — | 7/7/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 560 | $100K | 5/5/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 504 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 435 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 433 | $0 | 2/14/2023 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 1,208 | $608K | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 253 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 303 | $0 | 2/14/2023 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 4,445 | — | 2/10/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 192 | $0 | 8/5/2022 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 90 | $37K | 8/5/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 7,585 | — | 6/14/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 795 | $22K | 6/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 706 | $100K | 2/16/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 435 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 459 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 253 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 505 | $0 | 2/14/2022 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 964 | $487K | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 433 | $0 | 2/14/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,223 | — | 2/10/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 4,446 | — | 2/10/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,823 | $43K | 2/10/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 912 | $21K | 2/10/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 9,225 | $626K | 11/12/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,273 | $1.4M | 11/12/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 6,952 | $4.3M | 11/12/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,974 | $1.9M | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,262 | $784K | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,326 | $1.5M | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,813 | $1.1M | 11/10/2021 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 20,000 | $1.4M | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,493 | $931K | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 5,743 | $3.6M | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,142 | $1.3M | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,375 | $865K | 11/10/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 872 | $549K | 11/10/2021 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 6,310 | $428K | 11/9/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 607 | $383K | 11/9/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 5,703 | $3.6M | 11/9/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,100 | $689K | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 110 | $70K | 11/8/2021 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 10,000 | $679K | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 743 | $469K | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 971 | $612K | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,326 | $832K | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,356 | $1.5M | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,094 | $1.3M | 11/8/2021 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,300 | $813K | 11/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
XRAY: Earnings, Target Cut, Expansion, Medicare Coverage
XRAY reported its Q2 earnings, prompting analysts to review the company’s outlook. Piper Sandler lowered its target to $12, citing the reset strategy after a new Midwest dental partnership. Meanwhile, the Wellspect unit announced Medicare reimbursement for its Surity urinary portfolio, expanding the company’s product reach. These developments add new layers to XRAY’s growth narrative.
XRAY: Earnings, Target Cut, Expansion, Medicare Coverage. XRAY reported its Q2 earnings, prompting analysts to review the company’s outlook. Piper Sandler lowered its target to $12, citing the reset strategy after a new Midwest dental partnership. Meanwhile, the Wellspect unit announced Medicare reimbursement for its Surity urinary portfolio, expanding the company’s product reach. These developments add new layers to XRAY’s growth narrative.